Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland.
Saved in:
| Title: | Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland. |
|---|---|
| Authors: | Kind, André B.1, Pavelyev, Andrew2,3, Kothari, Smita2, El Mouaddin, Nadia4, Schmidt, Aurélie5, Morais, Edith6, Guggisberg, Patrik7, Lienert, Florian8 florian.lienert@merck.com |
| Source: | BMC Public Health. 5/12/2020, Vol. 20 Issue 1, p1-13. 13p. 3 Charts, 8 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
